Related Experiment Video

Updated: Oct 4, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

[Prevalence of silent myocardial ischemia in hypertensive patients and risk factors]

B A Pivniev

    Likars'Ka Sprava
    |August 25, 2001
    PubMed

    Insights

    Silent myocardial ischemia in hypertensive patients is linked to endothelial dysfunction. The severity of this dysfunction correlates with the duration of silent myocardial ischemia.

    Area of Science:

    • Cardiology
    • Vascular Biology
    • Hypertension Research

    Context:

    • Hypertension is a major risk factor for cardiovascular diseases, including silent myocardial ischemia.
    • Silent myocardial ischemia, often undiagnosed, poses significant health risks.
    • Endothelial dysfunction plays a critical role in the pathophysiology of various cardiovascular conditions.

    Purpose:

    • To investigate the prevalence and risk factors of silent myocardial ischemia in hypertensive patients.
    • To explore the association between endothelial dysfunction and silent myocardial ischemia in this population.
    • To determine if the degree of endothelial dysfunction correlates with the duration of silent myocardial ischemia.

    Summary:

    • This study highlights the significant role of endothelial dysfunction in the development of silent myocardial ischemia among hypertensive individuals.
    • Findings indicate a direct relationship between the extent of endothelial dysfunction and the duration of silent myocardial ischemia.
    • Prevalence and risk factors for silent myocardial ischemia were analyzed in hypertensive patients.

    Impact:

    • Provides crucial insights into the mechanisms underlying silent myocardial ischemia in hypertension.
    • Suggests endothelial function assessment as a potential diagnostic or prognostic tool.
    • Informs clinical strategies for managing hypertensive patients at risk for silent myocardial ischemia.

    Related Concept Videos

    Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

    Hypertension III: Clinical Manifestations and Diagnostic Studies

    Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
    Angina II: Classification01:27

    Angina II: Classification

    Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
    Hypertension I: Introduction01:28

    Hypertension I: Introduction

    Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
    Ischemic Heart Disease: Overview01:17

    Ischemic Heart Disease: Overview

    Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
    Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...